Promising therapy with genetically modified cells against Alzheimer's disease

Scientists have developed a revolutionary method for delivering therapeutic proteins directly to the brain using genetically engineered human microglia. This innovative approach promises to revolutionize the treatment of Alzheimer's disease and other neurological disorders by ensuring precise and effective delivery of therapeutic substances directly to affected brain regions.

A new treatment for Alzheimer's disease called Lecanemab authorised in Europe The European Commission has just approved the marketing of Lecanemab, an innovative medicine specifically developed to slow the progression of Alzheimer's disease. This decision, taken after the favourable opinion of the European Medicines Agency (EMA), marks a major step forward in the management of the early forms of this neurodegenerative pathology. What is Lecanema…